Skip to content

Erbe Elektromedizin Launches MOVIVA® at ESGE Days 2026

During its 175th anniversary, Erbe Elektromedizin GmbH launches MOVIVA®, a new minimally invasive solution for gastric mucosal ablation in endoscopic obesity therapy, at the ESGE Days conference in Milan, taking place from May 14 to 16, 2026.

TÜBINGEN, Germany–(BUSINESS WIRE)– #BariatricEndoscopy–During its 175th anniversary year, Erbe Elektromedizin GmbH highlights its continued commitment to healthcare innovation with the launch of MOVIVA®, a minimally invasive solution for gastric mucosal ablation (GMA) in endoscopic obesity therapy. MOVIVA® will be the central focus of Erbe’s activities at ESGE Days in Milan, 14–16 May 2026. Physicians can explore the technology in the hands-on area and attend a dedicated symposium. “Obesity continues to rise worl